Jan 28, 2019 10:33pm EST Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
Jan 09, 2019 8:00am EST Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
Nov 19, 2018 4:16pm EST Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
